Phase Iii Study of Neoadjuvant Pembrolizumab or Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab or Placebo for Early-Stage Triple-Negative Breast Cancer (Tnbc): Keynote-522 Korean Subgroup Analysis

AuthID
P-00Z-QT2
20
Author(s)
Park, YH
·
Im, SA
·
Ahn, JH
·
Kim, MH
·
Cortés, J
·
Dent, RA
·
Pusztai, L
·
McArthur, HL
·
Kummel, S
·
Denkert, C
·
O'Shaughnessy, J
·
Mouret Reynier, MA
·
Ferreira, MIR
·
Boileau, JF
·
Hui, R
·
Zhu, Y
·
Pan, W
·
Karantza, VV
·
Schmid, P
Document Type
Abstract
Year published
2023
Published
in ANNALS OF ONCOLOGY, ISSN: 0923-7534
Volume: 34, Pages: S1467-S1468 (2)
Conference
Annual Meeting of the European-Society-For-Medical-Oncology (Esmo), Date: DEC 01-03, 2023, Location: SINGAPORE
Indexing
Publication Identifiers
Wos: WOS:001122475400003
Source Identifiers
ISSN: 0923-7534
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.